Event Highlights

Here is a summary of everything you need to know about our summit

Topic Highlights

  • Addressing inconsistencies in regulatory frameworks across different EU regions and improving global collaboration.
  • Exploring the role of AI/ML in predicting adverse events and improving pharmacovigilance processes.
  • Enhancing the collection of real-world data to monitor the long-term safety of medications after they reach the market.
  • Improving Signal Detection through Big Data and Advanced Analytics: Leveraging large datasets and analytics to enhance the detection and evaluation of safety signals.
  • Effective communication of drug safety risks to healthcare professionals, patients, and the public.
  • Protecting sensitive data in drug safety systems, particularly as digital tools and cloud technologies become more prevalent.
  • Addressing the Rise of Counterfeit Drugs in Global Markets: Strategies for improving drug traceability and combatting counterfeit medicines that pose significant safety risks.
  • Ecopharmacovigilance: Reducing environmental impact and enhancing patient safety by integrating eco-pharmacovigilance practices.
  • Enhancing pharmacovigilance systems across the EU to ensure real-time monitoring and reporting of adverse drug reactions (ADRs)
  • Overcoming the Challenges in Implementing and Optimizing EudraVigilance for Drug Safety in the EU

Over 1 million adverse drug reactions are reported each year in Europe alone, highlighting the urgent need for vigilant pharmacovigilance practices. In today’s complex landscape, pharmacovigilance has become more essential than ever, with challenges like adverse reactions, unpredictable drug interactions, and gaps in cross-border regulations creating significant risks for patient safety. Join us at Pronovea’s 4th edition of Drug Safety and Risk Management Summit as we explore transformative trends, embrace real-world evidence, navigate the latest updates in pharmacovigilance and expanding its scope to address the emerging issues in pharmacovigilance today, offering new perspectives and actionable strategies that reflect the latest industry trends and challenges.

Network With

Members of board, C-level, GMs, Senior/Global Vice Presidents, Directors, Heads of departments from functions including:
  • Pharmacovigilance
  • Risk Management Planning
  • PV Collaborations
  • Drug Monitoring
  • Regional & Global Patient Safety
  • QPPVs
  • Medical Affairs
  • Clinical Safety
  • Clinical Research
  • Global PV Operations Safety
  • Scientific Affairs
  • Drug Safety
  • Safety Surveillance
  • Safety Officer
  • Signal Detection Management
  • Innovations and Digitalisation
  • Global R&D
  • Collection Compliance
  • REMS
  • Medical Product SafetyAssessment